CVA Family Office, LLC - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CVA Family Office, LLC ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q2 2023$289
-39.8%
5000.0%0.00%
Q1 2023$480
-9.4%
5000.0%0.00%
Q4 2022$530
-47.0%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,000
-50.0%
5000.0%0.00%
-100.0%
Q2 2021$2,0000.0%5000.0%0.00%0.0%
Q1 2021$2,0005000.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,040,529$3,122,0001.00%
OCCUDO QUANTITATIVE STRATEGIES LP 23,484$70,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 27,400$82,0000.00%
RAYMOND JAMES & ASSOCIATES 14,175$43,0000.00%
UBS Group AG 1,403$4,0000.00%
OSAIC HOLDINGS, INC. 801$2,0000.00%
BANK OF AMERICA CORP /DE/ 6,650$20,0000.00%
WELLS FARGO & COMPANY/MN 175$1,0000.00%
NORTHERN TRUST CORP 50,731$152,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MOLECULIN BIOTECH INC shareholders